ExoVex+30B and Stem 3 Protocol Offered for Hair Loss

springsrejuvenation.com Introduces ExoVex+30B Exosome Therapy and Stem 3 Protocol for Hair Restoration

Aventura, United States – June 4, 2026 / Springs Rejuvenation /

springsrejuvenation.com has formally introduced ExoVex+30B and its proprietary Stem 3 Protocol, a structured three-step hair restoration approach that combines peptide therapy, exosome-based treatment, and minimally invasive micro follicular unit extraction (micro FUE). The launch brings a research-backed framework to patients seeking alternatives to conventional hair loss treatment options.

What the Research Shows

The clinical foundation behind the new offerings draws on two recently published studies. A 2024 randomized controlled trial and a 2023 systematic review both examined exosome-based approaches to hair loss, with findings that support the biological rationale for using exosomes to may help support hair regrowth at the follicular level. Exosomes are extracellular vesicles known to carry signaling proteins and growth factors that interact with cells involved in hair follicle cycling.

springsrejuvenation.com points to these peer-reviewed publications as part of its rationale for structuring a protocol around exosome therapy hair restoration rather than relying on a single-modality approach. The combination of published evidence and a standardized delivery method is central to how the clinic positions the Stem 3 Protocol for prospective patients.

ExoVex+30B: Exosome Concentration and Application

At the core of the new offering is ExoVex+30B, a product containing 30 billion exosomes per treatment application. The concentration is designed to deliver a high volume of bioactive signaling molecules to targeted areas of the scalp. Patients have reported noticing changes in scalp condition and hair density following exosome-based sessions, though individual outcomes vary.

The product is administered as part of a broader protocol rather than as a standalone intervention. springsrejuvenation.com describes ExoVex+30B as a component designed to help optimize the biological environment of the scalp before and after procedural steps are performed.

These statements have not been evaluated by the FDA. These products and services are not intended to diagnose, treat, cure, or prevent any disease.

The Stem 3 Protocol: A Three-Step Framework

The Stem 3 Protocol is a proprietary sequence that integrates three distinct modalities in a coordinated order. The first step involves peptide therapy, which is used to prepare the scalp and may help support the cellular signaling environment prior to subsequent steps. The second step introduces stem cell hair regrowth support through the application of ExoVex+30B exosomes, targeting follicular units at the treatment site.

The third step involves micro FUE, performed with a 0.9mm punch instrument. The reduced punch diameter compared to conventional FUE tools is described by springsrejuvenation.com as designed to help minimize visible scarring at donor and recipient sites. The protocol is structured with a target graft success rate of 90% or higher, based on the design parameters of the combined approach.

The sequencing of peptide preparation, exosome delivery, and micro FUE is intended to create conditions where each step may help support the outcomes of the next, rather than treating each element as an independent variable.

Patient Eligibility and Clinical Context

springsrejuvenation.com notes that the Stem 3 Protocol is designed for patients who are evaluating structured, multi-modality approaches to hair loss. Patients have reported interest in the protocol particularly because of the reduced visible scarring profile associated with the 0.9mm micro FUE component, which may be relevant for those who prefer shorter hair styles or have concerns about donor site appearance.

The clinic positions exosome therapy hair restoration not as a replacement for surgical approaches in all cases, but as an integrated layer within a broader procedural framework. The inclusion of the ExoVex+30B product within the Stem 3 Protocol reflects the clinic’s approach of combining biologics with procedural techniques under a single structured plan.

Consultations regarding the ExoVex+30B product and Stem 3 Protocol can be directed to springsrejuvenation.com by phone at (305) 363-0718 or by email at drcharles@springsrejuvenation.com.

About springsrejuvenation.com

springsrejuvenation.com offers hair restoration and regenerative services including the ExoVex+30B exosome product and the proprietary Stem 3 Protocol, a three-step approach combining peptide therapy, exosome delivery, and 0.9mm micro FUE. The clinic’s protocols are informed by published clinical research, including a 2024 randomized controlled trial and a 2023 systematic review on exosome-based hair restoration approaches.

Learn more at Springs Rejuvenation